{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:11:06Z","timestamp":1792804266412,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012234","name":"Shenzhen Peacock Plan","doi-asserted-by":"publisher","award":["KQTD2016053117035204"],"award-info":[{"award-number":["KQTD2016053117035204"]}],"id":[{"id":"10.13039\/501100012234","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81630096"],"award-info":[{"award-number":["81630096"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021177","name":"Shenzhen Bay Laboratory","doi-asserted-by":"publisher","award":["SZBL2019062801007"],"award-info":[{"award-number":["SZBL2019062801007"]}],"id":[{"id":"10.13039\/501100021177","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.abb.2025.110366","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T11:49:33Z","timestamp":1740656973000},"page":"110366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Role of protein disulfide isomerase in mediating sulfasalazine-induced ferroptosis in HT22 cells: The PDI\u2212NOS\u2013NO\u2212ROS\/lipid-ROS cascade"],"prefix":"10.1016","volume":"768","author":[{"given":"Yufei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao Ting","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abb.2025.110366_bib1","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.3748\/wjg.v20.i12.3146","article-title":"Immunosuppressive therapies for inflammatory bowel disease","volume":"20","author":"Zenlea","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.abb.2025.110366_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.7326\/0003-4819-101-3-377","article-title":"Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development","volume":"101","author":"Peppercorn","year":"1984","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.abb.2025.110366_bib3","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1053\/gast.2000.19458","article-title":"Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta","volume":"119","author":"Weber","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.abb.2025.110366_bib4","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1172\/JCI992","article-title":"Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B","volume":"101","author":"Wahl","year":"1998","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.abb.2025.110366_bib5","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1440-1746.2005.03862.x","article-title":"Sulfasalazine inhibits activation of nuclear factor-kappaB in patients with ulcerative colitis","volume":"20","author":"Gan","year":"2005","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.abb.2025.110366_bib6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1517\/13543784.2012.670634","article-title":"Sulfasalazine for brain cancer fits","volume":"21","author":"Sontheimer","year":"2012","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.abb.2025.110366_bib7","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/sj.leu.2402238","article-title":"Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drug","volume":"15","author":"Gout","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.abb.2025.110366_bib8","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.3892\/ol.2020.11813","article-title":"xCT inhibitor sulfasalazine depletes paclitaxel-resistant tumor cells through ferroptosis in uterine serous carcinoma","volume":"20","author":"Sugiyama","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.abb.2025.110366_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15082363","article-title":"Repurposing sulfasalazine as a radiosensitizer in hypoxic human colorectal cancer","volume":"15","author":"Kerkhove","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.abb.2025.110366_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/srep41382","article-title":"Behavioural effects of using sulfasalazine to inhibit glutamate released by cancer cells: a novel target for cancer-induced depression","volume":"7","author":"Nashed","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.abb.2025.110366_bib11","first-page":"3106","article-title":"SLC7A11\/xCT in cancer: biological functions and therapeutic implications","volume":"10","author":"Lin","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.abb.2025.110366_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canlet.2015.07.031","article-title":"Xc- inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism","volume":"368","author":"Ma","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.abb.2025.110366_bib13","first-page":"1011","article-title":"Piperlongumine rapidly induces the death of human pancreatic cancer cells mainly through the induction of ferroptosis","volume":"52","author":"Yamaguchi","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.abb.2025.110366_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122411","article-title":"Regulatory network of ferroptosis and autophagy by targeting oxidative stress defense using sulfasalazine in triple-negative breast cancer","volume":"339","author":"Takatani-Nakase","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.abb.2025.110366_bib15","first-page":"826","article-title":"Sulfasalazine-induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor","volume":"42","author":"Yu","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.abb.2025.110366_bib16","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.abb.2025.110366_bib17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.abb.2025.110366_bib18","article-title":"Characteristics and biomarkers of ferroptosis","volume":"9","author":"Chen","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.abb.2025.110366_bib19","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","article-title":"Mechanisms of ferroptosis","volume":"73","author":"Cao","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.abb.2025.110366_bib20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons: the role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.abb.2025.110366_bib21","doi-asserted-by":"crossref","first-page":"16218","DOI":"10.1016\/S0021-9258(18)37581-1","article-title":"Characterization of the human gene for a polypeptide that acts both as the beta subunit of prolyl 4-hydroxylase and as protein disulfide isomerase","volume":"263","author":"Tasanen","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2025.110366_bib22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/j.1460-2075.1987.tb04803.x","article-title":"Molecular cloning of the beta-subunit of human prolyl 4-hydroxylase. This subunit and protein disulphide isomerase are products of the same gene","volume":"6","author":"Pihlajaniemi","year":"1987","journal-title":"EMBO J."},{"key":"10.1016\/j.abb.2025.110366_bib23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0968-0004(94)90072-8","article-title":"Protein disulphide isomerase: building bridges in protein folding","volume":"19","author":"Freedman","year":"1994","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.abb.2025.110366_bib24","doi-asserted-by":"crossref","first-page":"24550","DOI":"10.1016\/S0021-9258(17)31426-6","article-title":"Chaperone-like activity of protein disulfide isomerase in the refolding of a protein with no disulfide bonds","volume":"269","author":"Cai","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2025.110366_bib25","doi-asserted-by":"crossref","first-page":"32705","DOI":"10.1074\/jbc.M111.227181","article-title":"Functional in vitro analysis of the ERO1 protein and protein-disulfide isomerase pathway","volume":"286","author":"Araki","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2025.110366_bib26","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2011.0403","article-title":"Ero1-PDI interactions, the response to redox flux and the implications for disulfide bond formation in the mammalian endoplasmic reticulum","volume":"368","author":"Benham","year":"2013","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.abb.2025.110366_bib27","doi-asserted-by":"crossref","first-page":"9114","DOI":"10.1016\/S0021-9258(19)38819-2","article-title":"Protein disulfide-isomerase is a substrate for thioredoxin reductase and has thioredoxin-like activity","volume":"265","author":"Lundstr\u00f6m","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2025.110366_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/mcb.00522-21","article-title":"Mechanism of erastin-induced ferroptosis in MDA-MB-231 human breast cancer cells: evidence for a critical role of protein disulfide isomerase","volume":"42","author":"Wang","year":"2022","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.abb.2025.110366_bib29","first-page":"853","article-title":"Biochemical mechanism of erastin-induced ferroptotic cell death in neuronal cells","volume":"55","author":"Hou","year":"2023","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.abb.2025.110366_bib30","article-title":"Mechanism of RSL3-induced ferroptotic cell death in HT22 cells: crucial role of protein disulfide isomerase","author":"Hou","year":"2024","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.abb.2025.110366_bib31","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.bbrc.2016.06.066","article-title":"Protein disulfide isomerase mediates glutathione depletion-induced cytotoxicity","volume":"477","author":"Okada","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.abb.2025.110366_bib32","doi-asserted-by":"crossref","first-page":"7283","DOI":"10.1038\/s41598-020-62984-y","article-title":"4-Hydroxyestrone, an endogenous estrogen metabolite, can strongly protect neuronal cells against oxidative damage","volume":"10","author":"Choi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.abb.2025.110366_bib33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.abb.2025.110366_bib34","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4103\/1673-5374.266060","article-title":"Ferrostatin-1 protects HT-22 cells from oxidative toxicity","volume":"15","author":"Chu","year":"2020","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.abb.2025.110366_bib35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1023\/B:NEON.0000024238.21349.37","article-title":"Desferoxamine (DFO)--mediated iron chelation: rationale for a novel approach to therapy for brain cancer","volume":"67","author":"Dayani","year":"2004","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.abb.2025.110366_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105297","article-title":"Necrostatin-1 and necroptosis inhibition: pathophysiology and therapeutic implications","volume":"163","author":"Cao","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.abb.2025.110366_bib37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1078\/0065-1281-00601","article-title":"The history of Z-VAD-FMK, a tool for understanding the significance of caspase inhibition","volume":"103","author":"Van Noorden","year":"2001","journal-title":"Acta Histochem."},{"key":"10.1016\/j.abb.2025.110366_bib38","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41419-022-05066-3","article-title":"Regulated necrosis, a proinflammatory cell death, potentially counteracts pathogenic infections","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.abb.2025.110366_bib39","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/0897190018776396","article-title":"Sodium nitroprusside as a hyperinflation drug and therapeutic alternatives","volume":"31","author":"Cobb","year":"2018","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.abb.2025.110366_bib40","doi-asserted-by":"crossref","first-page":"50949","DOI":"10.1074\/jbc.M308317200","article-title":"Reactions of PTIO and carboxy-PTIO with \u2217NO, \u2217NO2, and O2-","volume":"278","author":"Goldstein","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.abb.2025.110366_bib41","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0008-6363(99)00115-7","article-title":"Enzymatic function of nitric oxide synthases","volume":"43","author":"Andrew","year":"1999","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.abb.2025.110366_bib42","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"Forstermann","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.abb.2025.110366_bib43","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1006\/bbrc.1993.2246","article-title":"Chlorpromazine inhibits both the constitutive nitric oxide synthase and the induction of nitric oxide synthase after LPS challenge","volume":"196","author":"Palacios","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.abb.2025.110366_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23123305","article-title":"Overview on the effects of N-acetylcysteine in neurodegenerative diseases","volume":"23","author":"Tardiolo","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.abb.2025.110366_bib45","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bbrc.2017.05.118","article-title":"Cystamine-mediated inhibition of protein disulfide isomerase triggers aggregation of misfolded orexin-A in the Golgi apparatus and prevents extracellular secretion of orexin-A","volume":"489","author":"Fujita","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.abb.2025.110366_bib46","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1021\/acs.biochem.3c00261","article-title":"Strong protection by 4-hydroxyestrone against erastin-induced ferroptotic cell death in estrogen receptor-negative human breast cancer cells: evidence for protein disulfide isomerase as a mechanistic target for protection","volume":"63","author":"Wang","year":"2024","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2025.110366_bib47","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/bab.2150","article-title":"A comprehensive review on anticancer mechanism of bazedoxifene","volume":"69","author":"Zafar","year":"2022","journal-title":"Biotechnol. Appl. Biochem."},{"issue":"6","key":"10.1016\/j.abb.2025.110366_bib48","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41589-021-00751-4","article-title":"A compendium of kinetic modulatory profiles identifies ferroptosis regulators","volume":"17","author":"Conlon","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.abb.2025.110366_bib49","doi-asserted-by":"crossref","first-page":"L545","DOI":"10.1152\/ajplung.00214.2018","article-title":"The thioredoxin reductase inhibitor auranofin induces heme oxygenase-1 in lung epithelial cells via Nrf2-dependent mechanisms","volume":"315","author":"Dunigan","year":"2018","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.abb.2025.110366_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102703","article-title":"The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1","volume":"62","author":"Cheff","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.abb.2025.110366_bib51","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1523\/JNEUROSCI.5258-04.2005","article-title":"Inhibition of cystine uptake disrupts the growth of primary brain tumors","volume":"25","author":"Chung","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.abb.2025.110366_bib52","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/bbb\/zbad117","article-title":"3,6-Epidioxy-1,10-bisaboladiene and sulfasalazine synergistically induce ferroptosis-like cell death in human breast cancer cell lines","volume":"87","author":"Usukhbayar","year":"2023","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.abb.2025.110366_bib53","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/cbdd.14281","article-title":"Sulfasalazine inhibits esophageal cancer cell proliferation by mediating ferroptosis","volume":"102","author":"Yin","year":"2023","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.abb.2025.110366_bib54","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1016\/j.ymthe.2021.03.013","article-title":"Inhibition of xCT suppresses the efficacy of anti-PD-1\/L1 melanoma treatment through exosomal PD-L1-induced macrophage M2 polarization","volume":"29","author":"Liu","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.abb.2025.110366_bib55","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1471-4159.2009.06129.x","article-title":"Sulfasalazine inhibits the growth of primary brain tumors independent of nuclear factor-kappaB","volume":"110","author":"Chung","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.abb.2025.110366_bib56","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI124049","article-title":"Suppression of the SLC7A11\/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma","volume":"130","author":"Hu","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.abb.2025.110366_bib57","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.1038\/onc.2015.60","article-title":"Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc-, leading to glutathione depletion","volume":"34","author":"Sleire","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.abb.2025.110366_bib58","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7862430","article-title":"Hypoxia enhances glioma resistance to sulfasalazine-induced ferroptosis by upregulating SLC7A11 via PI3K\/AKT\/HIF-1alpha Axis","volume":"2022","author":"Sun","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.abb.2025.110366_bib59","article-title":"Sulfasalazine induces autophagy inhibiting neointimal hyperplasia following carotid artery injuries in mice","volume":"11","author":"Zhang","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.abb.2025.110366_bib60","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4103\/0028-3886.128280","article-title":"Sulfasalazine and temozolomide with radiation therapy for newly diagnosed glioblastoma","volume":"62","author":"Takeuchi","year":"2014","journal-title":"Neurol. India"},{"key":"10.1016\/j.abb.2025.110366_bib61","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2407-6-29","article-title":"A phase 1-2, prospective, double blind, randomized study of the safety and efficacy of Sulfasalazine for the treatment of progressing malignant gliomas: study protocol of [ISRCTN45828668]","volume":"6","author":"Robe","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.abb.2025.110366_bib62","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/1471-2407-9-372","article-title":"Early termination of ISRCTN45828668, a phase 1\/2 prospective, randomized study of sulfasalazine for the treatment of progressing malignant gliomas in adults","volume":"9","author":"Robe","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.abb.2025.110366_bib63","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s10120-017-0720-y","article-title":"Phase 1 study of sulfasalazine and cisplatin for patients with CD44v-positive gastric cancer refractory to cisplatin (EPOC1407)","volume":"20","author":"Shitara","year":"2017","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.abb.2025.110366_bib64","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12885-023-11797-z","article-title":"A phase Ib\/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol","volume":"24","author":"Mastall","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.abb.2025.110366_bib65","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1021\/bi00054a013","article-title":"Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor\/.NO through a radical reaction","volume":"32","author":"Akaike","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.abb.2025.110366_bib66","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0891-0618(96)00148-2","article-title":"Nitric oxide neurotoxicity","volume":"10","author":"Dawson","year":"1996","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.abb.2025.110366_bib67","first-page":"273","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism","volume":"171","author":"Stockwell","year":"2017","journal-title":"Redox Biology, and Disease, Cell"},{"key":"10.1016\/j.abb.2025.110366_bib68","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1006\/abbi.2000.2048","article-title":"Effect of S-nitrosothiols on cellular glutathione and reactive protein sulfhydryls","volume":"383","author":"Mallis","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.abb.2025.110366_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111004","article-title":"Therapeutic targeting of thioredoxin reductase 1 causes ferroptosis while potentiating anti-PD-1 efficacy in head and neck cancer","volume":"395","author":"Hsieh","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.abb.2025.110366_bib70","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/ard.35.3.251","article-title":"Auranofin. New oral gold compound for treatment of rheumatoid arthritis","volume":"35","author":"Finkelstein","year":"1976","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.abb.2025.110366_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108272","article-title":"Auranofin: past to present, and repurposing","volume":"101","author":"Yamashita","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.abb.2025.110366_bib72","doi-asserted-by":"crossref","first-page":"25257","DOI":"10.1021\/acsnano.3c08485","article-title":"Reversing ferroptosis resistance in breast cancer via tailored lipid and iron presentation","volume":"17","author":"Luo","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.abb.2025.110366_bib73","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41392-020-00253-0","article-title":"Auranofin mitigates systemic iron overload and induces ferroptosis via distinct mechanisms","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.abb.2025.110366_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.883297","article-title":"The role of the thioredoxin detoxification system in cancer progression and resistance","volume":"9","author":"Jovanovic","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.abb.2025.110366_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.niox.2013.10.009","article-title":"Long-term aerobic exercise increases redox-active iron through nitric oxide in rat hippocampus","volume":"36","author":"Chen","year":"2014","journal-title":"Nitric Oxide"}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986125000797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986125000797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T13:06:35Z","timestamp":1762088795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986125000797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":75,"alternative-id":["S0003986125000797"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2025.110366","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of protein disulfide isomerase in mediating sulfasalazine-induced ferroptosis in HT22 cells: The PDI\u2212NOS\u2013NO\u2212ROS\/lipid-ROS cascade","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2025.110366","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110366"}}